775 related articles for article (PubMed ID: 8835558)
1. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
[TBL] [Abstract][Full Text] [Related]
2. Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase.
van Lent PL; van den Hoek AE; van den Bersselaar LA; van de Loo FA; Eykholt HE; Brouwer WF; van de Putte LB; van den Berg WB
J Rheumatol; 1994 Feb; 21(2):321-9. PubMed ID: 8182644
[TBL] [Abstract][Full Text] [Related]
3. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
van de Loo FA; Kuiper S; van Enckevort FH; Arntz OJ; van den Berg WB
Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
[TBL] [Abstract][Full Text] [Related]
5. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
8. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
10. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.
Lubberts E; Joosten LA; Helsen MM; van den Berg WB
Cytokine; 1998 May; 10(5):361-9. PubMed ID: 9619374
[TBL] [Abstract][Full Text] [Related]
11. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis.
van de Loo FA; Arntz OJ; Otterness IG; van den Berg WB
J Rheumatol; 1992 Mar; 19(3):348-56. PubMed ID: 1578447
[TBL] [Abstract][Full Text] [Related]
12. Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis.
van Lent PL; Holthuysen AE; van Rooijen N; van de Loo FA; van de Putte LB; van den Berg WB
J Rheumatol; 1998 Jun; 25(6):1135-45. PubMed ID: 9632077
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.
van de Loo AA; Arntz OJ; Bakker AC; van Lent PL; Jacobs MJ; van den Berg WB
Am J Pathol; 1995 Jan; 146(1):239-49. PubMed ID: 7856731
[TBL] [Abstract][Full Text] [Related]
14. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
15. Cationic immune complex arthritis in mice--a new model. Synergistic effect of complement and interleukin-1.
van Lent PL; van den Bersselaar LA; van den Hoek AE; van de Loo AA; van den Berg WB
Am J Pathol; 1992 Jun; 140(6):1451-61. PubMed ID: 1605310
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint.
van Beuningen HM; van der Kraan PM; Arntz OJ; van den Berg WB
Lab Invest; 1994 Aug; 71(2):279-90. PubMed ID: 8078307
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
18. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis.
van de Loo FA; Joosten LA; van Lent PL; Arntz OJ; van den Berg WB
Arthritis Rheum; 1995 Feb; 38(2):164-72. PubMed ID: 7848306
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
